<PAGE>
- --------------------------------------------------------------------------------
SEC 1746 Potential persons who are to respond to the collection of information
contained in this form are not (2-98) required to respond unless the form
displays a currently valid OMB control number.
- --------------------------------------------------------------------------------
-------------------------------
OMB APPROVAL
-------------------------------
OMB Number: 3235-0145
-------------------------------
Expires: November 30, 1999
-------------------------------
Estimated average burden
hours per response. . . 14.9
-------------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. _5_______)*
ASTREX, INC.
- --------------------------------------------------------------------------------
(Name of Issuer)
Astrex, Inc. Common Stock
- --------------------------------------------------------------------------------
(Title of Class of Securities)
04635-20-8
- --------------------------------------------------------------------------------
(CUSIP Number)
John C. Loring 700 W. Irving Park Rd., Chicago, IL 60613
- --------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
1/31/00
- --------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to
report the acquisition that is the subject of this Schedule 13D, and is
filing this schedule because of ss.ss.240.13d-1(e), 240.13d-1(f) or
240.13d-1(g), check the following box. [ ]
Note: Schedules filed in paper format shall include a signed original and
five copies of the schedule, including all exhibits. See ss.240.13d-7 for
other parties to whom copies are to be sent.
* The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities
Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of
that section of the Act but shall be subject to all other provisions of the
Act (however, see the Notes).
<PAGE>
- -------------------------------------------------------------------------------
CUSIP No. 04635-20-8 Amendment #5 SCHEDULE 13D Page 2 of 3
- -------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS. I.R.S. IDENTIFICATION NOS. OF ABOVE
PERSONS (ENTITIES ONLY).
John C. Loring SS# ###-##-####
Elizabeth J/S Loring SS# ###-##-####
- ------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(SEE INSTRUCTIONS) (a) [ ]
(b) [x]
- ------------------------------------------------------------------------------
3 SEC USE ONLY
- ------------------------------------------------------------------------------
4 SOURCE OF FUNDS (SEE INSTRUCTIONS)
N/A
- ------------------------------------------------------------------------------
5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e)
- -------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
USA/ILLINOIS
- -------------------------------------------------------------------------------
| | SOLE VOTING POWER
NUMBER OF | 7 | John C. Loring 1,821,810 shares
SHARES | | Elizabeth Loring 271,970 shares
BENEFICIALLY |_____|________________________________________________________
OWNED BY | |
EACH | 8 | SHARED VOTING POWER
REPORTING | | John & Elizabeth Loring 15,000 shares
PERSON WITH |_____|________________________________________________________
| |
| 9 | SOLE DISPOSITIVE POWER
| | See 7
|-----|--------------------------------------------------------
| |
| 10 | SHARED DISPOSITIVE POWER
| | See 8
- ---------------|-----|---------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
SEE 7 & 8
- ------------------------------------------------------------------------------
12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES (SEE INSTRUCTIONS)
- ------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
37.46%
- ------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IN (EP)
- ------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT
<PAGE>
Schedule 13D
Amendment No. 5
CUSIP 046357-20-8 Page 3 of 3
John C. Loring
This Amendment No. 5 is filed to report a reduction in shares held due to sales
on the open market of 71,483 shares of the Company. There are no other changes
to Schedule 13D, as amended by Amendment No. 4 ( the 'fourth amendment") to
which this Amendment No. 5 (the "fifth amendment") relates to except as set
forth in this fifth amendment.
Item 4. Purpose of Transaction.
Between November 24, 1999 and January 31, 2000 Mr. Loring sold a total of 71,
483 shares of the Company on the open market for the purpose of raising cash.
Item 5. Interest in Securities of the Issuer. (a) In aggregate Mr. And Mrs.
Loring own or control 2,108,780 shares of Astrex, Inc. common stock representing
approximately 37.46 % of the approximately 5,629,277 outstanding shares.
Signatures.
After reasonable inquiry and the best of my knowledge and belief, I certify that
the information set forth in this statement is true complete and correct.
January 31, 2000
/s/ John C. Loring /s/ Elizabeth J./S. Loring
------------------ --------------------------
John C. Loring Elizabeth J./S. Loring
